The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF alpha production. The invention further relates to assays for the identification of an individual at increased risk for or suffering front such conditions and to methods of screening compounds for their ability to enhance TNF alpha biosynthesis.